NDLI: Clozapine and Several Other Antipsychotic/Antidepressant Drugs Preferentially Block the Same ‘Core’ Fraction of GABA$

Content Provider	Springer Nature Link
Author	Squires, Richard F. Saederup, Else
Copyright Year	1998
Abstract	Clozapine and several other antipsychotic/antidepressant drugs that fully or partially block GABA$_{A}$ receptors were tested at concentrations that reversed the inhibitory effect of 1 μM GABA on $^{35}$S-t-butylbicyclophosphorothionate ([$^{35}$S]TBPS) binding to rat forebrain membranes only about 20–30%, here designated “core” fractions. Clozapine at 10 μM reverses 1 μM GABA 25 ± 4.0% (n = 23) (its “core” fraction). Fourty three compounds were tested alone, and pairwise together with 10 μM Clozapine. The “core” fractions of some of the compounds yielded significant additive reversals together with 10 μM Clozapine, while others did not. A group of 14 compounds of which 7 are clinically effective antipsychotic drugs, including Chlorprothixene, Clomacran, Clopipazan, Fluotracen, Sulforidazine, Thioproperazine, and cis-Thiothixene, were statistically non-additive with 10 μM Clozapine, suggesting that all of these drugs selectively block the same core population of GABA$_{A}$ receptors as Clozapine. These non-additivities also suggest that Clozapine at 10 μM fully saturates a subset of GABA$_{A}$ receptors blocked by 1 μM GABA. Therefore, Clozapine probably blocks 2 or more types of GABA$_{A}$ receptors, but only half of the receptors that are sensitive to 1 μM GABA. A second group of 12 compounds of which 6 are clinically active antidepressant/antipsychotic drugs including Amoxapine, Clothiapine, Dibenzepine, Inkasan (Metralindole), Metiapine and Zimelidine were slightly, but significantly, additive with Clozapine suggesting that these compounds block most of Clozapine's core fraction, plus a small additional fraction. A third group consisted of ten compounds that yielded larger (R > 80) and statistically highly significant additivities with Clozapine. Complete additivity was obtained with Bathophenanthroline disulfonate, and Isocarboxazid, suggesting that they block GABA$_{A}$ receptors other than those blocked by 10 μM Clozapine. Seven “classical” GABA$_{A}$ receptor blockers, also tested at concentrations yielding 21 to 33% reversal alone, were all significantly additive with 10 μM Clozapine, but in no case was the additivity complete. The largest additivity was obtained with Pitrazepine (21%) and the smallest with Tubocurarine (9%). These results provide further support for the notion that selective blockade of the same subset of GABA$_{A}$ receptors may contribute to the clinical antipsychotic/antidepressant effects of Clozapine. The ΔB$_{opt}$ values for Clozapine are 50 ± 1.7% and 26 ± 2.6% ( n = 3) in whole rat forebrain and cerebellum, respectively, confirming that clozapine-sensitive GABA$_{A}$ receptors are unevenly distributed in the brain. The sedative and anxiolytic properties of Clozapine and other antipsychotic drugs may be due to selective blockade of GABergic disinhibition at certain interneurons.
Starting Page	1283
Ending Page	1290
Page Count	8
File Format	PDF
ISSN	03643190
Journal	Neurochemical Research
Volume Number	23
Issue Number	10
e-ISSN	15736903
Language	English
Publisher	Kluwer Academic Publishers-Plenum Publishers
Publisher Date	1998-01-01
Publisher Place	New York
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Neurosciences Neurology Biochemistry
Content Type	Text
Resource Type	Article
Subject	Medicine Biochemistry Cellular and Molecular Neuroscience

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Clozapine and Some Other Antipsychotic Drugs May Preferentially Block the Same Subset of GABA$_{A}$ Receptors

Effects of Typical and Atypical Antipsychotic Drugs on Rat Brain Muscarinic Receptors

Muscimol as an Ionotropic GABA Receptor Agonist

GABA Pharmacology: The Search for Analgesics

Neurochemicals for the Investigation of GABA$_{C}$ Receptors

Allosteric Drugs Acting at Muscarinic Acetylcholine Receptors

Metabotropic Glutamate Receptors Modulate GABA Release from Mouse Hippocampal Slices

Modulation of Ionotropic GABA Receptors by 6-Methoxyflavanone and 6-Methoxyflavone

Long-term Effects of JL 13, a Potential Atypical Antipsychotic, on Ionotropic Glutamate Receptors

Clozapine and Several Other Antipsychotic/Antidepressant Drugs Preferentially Block the Same ‘Core’ Fraction of GABA$_{A}$ Receptors

Similar Documents

Clozapine and Some Other Antipsychotic Drugs May Preferentially Block the Same Subset of GABA$_{A}$ Receptors

Effects of Typical and Atypical Antipsychotic Drugs on Rat Brain Muscarinic Receptors

Muscimol as an Ionotropic GABA Receptor Agonist

GABA Pharmacology: The Search for Analgesics

Neurochemicals for the Investigation of GABA$_{C}$ Receptors

Allosteric Drugs Acting at Muscarinic Acetylcholine Receptors

Metabotropic Glutamate Receptors Modulate GABA Release from Mouse Hippocampal Slices

Modulation of Ionotropic GABA Receptors by 6-Methoxyflavanone and 6-Methoxyflavone

Long-term Effects of JL 13, a Potential Atypical Antipsychotic, on Ionotropic Glutamate Receptors

Clozapine and Several Other Antipsychotic/Antidepressant Drugs Preferentially Block the Same ‘Core’ Fraction of GABA$_{A}$ Receptors